Opioids Market

Global Opioids Market Size, Share & Industry Trends Analysis Report By Application (Pain Management, Cough Treatment and Diarrhea Treatment), By Product Type, By Regional Outlook and Forecast, 2021 - 2027

Report Id: KBV-8427 Publication Date: April-2022 Number of Pages: 180
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Opioids Market, by Application
1.4.2 Global Opioids Market, by Product Type
1.4.3 Global Opioids Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Opioids Market by Application
3.1 Global Pain Management Market by Region
3.2 Global Cough Treatment Market by Region
3.3 Global Diarrhea Treatment Market by Region

Chapter 4. Global Opioids Market by Product Type
4.1 Global Methadone Market by Region
4.2 Global Oxycodone Market by Region
4.3 Global Hydrocodone Market by Region
4.4 Global Fentanyl Market by Region
4.5 Global Codeine Market by Region
4.6 Global Morphine Market by Region
4.7 Global Other Product Type Market by Region

Chapter 5. Global Opioids Market by Region
5.1 North America Opioids Market
5.1.1 North America Opioids Market by Application
5.1.1.1 North America Pain Management Market by Country
5.1.1.2 North America Cough Treatment Market by Country
5.1.1.3 North America Diarrhea Treatment Market by Country
5.1.2 North America Opioids Market by Product Type
5.1.2.1 North America Methadone Market by Country
5.1.2.2 North America Oxycodone Market by Country
5.1.2.3 North America Hydrocodone Market by Country
5.1.2.4 North America Fentanyl Market by Country
5.1.2.5 North America Codeine Market by Country
5.1.2.6 North America Morphine Market by Country
5.1.2.7 North America Other Product Type Market by Country
5.1.3 North America Opioids Market by Country
5.1.3.1 US Opioids Market
5.1.3.1.1 US Opioids Market by Application
5.1.3.1.2 US Opioids Market by Product Type
5.1.3.2 Canada Opioids Market
5.1.3.2.1 Canada Opioids Market by Application
5.1.3.2.2 Canada Opioids Market by Product Type
5.1.3.3 Mexico Opioids Market
5.1.3.3.1 Mexico Opioids Market by Application
5.1.3.3.2 Mexico Opioids Market by Product Type
5.1.3.4 Rest of North America Opioids Market
5.1.3.4.1 Rest of North America Opioids Market by Application
5.1.3.4.2 Rest of North America Opioids Market by Product Type
5.2 Europe Opioids Market
5.2.1 Europe Opioids Market by Application
5.2.1.1 Europe Pain Management Market by Country
5.2.1.2 Europe Cough Treatment Market by Country
5.2.1.3 Europe Diarrhea Treatment Market by Country
5.2.2 Europe Opioids Market by Product Type
5.2.2.1 Europe Methadone Market by Country
5.2.2.2 Europe Oxycodone Market by Country
5.2.2.3 Europe Hydrocodone Market by Country
5.2.2.4 Europe Fentanyl Market by Country
5.2.2.5 Europe Codeine Market by Country
5.2.2.6 Europe Morphine Market by Country
5.2.2.7 Europe Other Product Type Market by Country
5.2.3 Europe Opioids Market by Country
5.2.3.1 Germany Opioids Market
5.2.3.1.1 Germany Opioids Market by Application
5.2.3.1.2 Germany Opioids Market by Product Type
5.2.3.2 UK Opioids Market
5.2.3.2.1 UK Opioids Market by Application
5.2.3.2.2 UK Opioids Market by Product Type
5.2.3.3 France Opioids Market
5.2.3.3.1 France Opioids Market by Application
5.2.3.3.2 France Opioids Market by Product Type
5.2.3.4 Russia Opioids Market
5.2.3.4.1 Russia Opioids Market by Application
5.2.3.4.2 Russia Opioids Market by Product Type
5.2.3.5 Spain Opioids Market
5.2.3.5.1 Spain Opioids Market by Application
5.2.3.5.2 Spain Opioids Market by Product Type
5.2.3.6 Italy Opioids Market
5.2.3.6.1 Italy Opioids Market by Application
5.2.3.6.2 Italy Opioids Market by Product Type
5.2.3.7 Rest of Europe Opioids Market
5.2.3.7.1 Rest of Europe Opioids Market by Application
5.2.3.7.2 Rest of Europe Opioids Market by Product Type
5.3 Asia Pacific Opioids Market
5.3.1 Asia Pacific Opioids Market by Application
5.3.1.1 Asia Pacific Pain Management Market by Country
5.3.1.2 Asia Pacific Cough Treatment Market by Country
5.3.1.3 Asia Pacific Diarrhea Treatment Market by Country
5.3.2 Asia Pacific Opioids Market by Product Type
5.3.2.1 Asia Pacific Methadone Market by Country
5.3.2.2 Asia Pacific Oxycodone Market by Country
5.3.2.3 Asia Pacific Hydrocodone Market by Country
5.3.2.4 Asia Pacific Fentanyl Market by Country
5.3.2.5 Asia Pacific Codeine Market by Country
5.3.2.6 Asia Pacific Morphine Market by Country
5.3.2.7 Asia Pacific Other Product Type Market by Country
5.3.3 Asia Pacific Opioids Market by Country
5.3.3.1 China Opioids Market
5.3.3.1.1 China Opioids Market by Application
5.3.3.1.2 China Opioids Market by Product Type
5.3.3.2 Japan Opioids Market
5.3.3.2.1 Japan Opioids Market by Application
5.3.3.2.2 Japan Opioids Market by Product Type
5.3.3.3 India Opioids Market
5.3.3.3.1 India Opioids Market by Application
5.3.3.3.2 India Opioids Market by Product Type
5.3.3.4 South Korea Opioids Market
5.3.3.4.1 South Korea Opioids Market by Application
5.3.3.4.2 South Korea Opioids Market by Product Type
5.3.3.5 Singapore Opioids Market
5.3.3.5.1 Singapore Opioids Market by Application
5.3.3.5.2 Singapore Opioids Market by Product Type
5.3.3.6 Malaysia Opioids Market
5.3.3.6.1 Malaysia Opioids Market by Application
5.3.3.6.2 Malaysia Opioids Market by Product Type
5.3.3.7 Rest of Asia Pacific Opioids Market
5.3.3.7.1 Rest of Asia Pacific Opioids Market by Application
5.3.3.7.2 Rest of Asia Pacific Opioids Market by Product Type
5.4 LAMEA Opioids Market
5.4.1 LAMEA Opioids Market by Application
5.4.1.1 LAMEA Pain Management Market by Country
5.4.1.2 LAMEA Cough Treatment Market by Country
5.4.1.3 LAMEA Diarrhea Treatment Market by Country
5.4.2 LAMEA Opioids Market by Product Type
5.4.2.1 LAMEA Methadone Market by Country
5.4.2.2 LAMEA Oxycodone Market by Country
5.4.2.3 LAMEA Hydrocodone Market by Country
5.4.2.4 LAMEA Fentanyl Market by Country
5.4.2.5 LAMEA Codeine Market by Country
5.4.2.6 LAMEA Morphine Market by Country
5.4.2.7 LAMEA Other Product Type Market by Country
5.4.3 LAMEA Opioids Market by Country
5.4.3.1 Brazil Opioids Market
5.4.3.1.1 Brazil Opioids Market by Application
5.4.3.1.2 Brazil Opioids Market by Product Type
5.4.3.2 Argentina Opioids Market
5.4.3.2.1 Argentina Opioids Market by Application
5.4.3.2.2 Argentina Opioids Market by Product Type
5.4.3.3 UAE Opioids Market
5.4.3.3.1 UAE Opioids Market by Application
5.4.3.3.2 UAE Opioids Market by Product Type
5.4.3.4 Saudi Arabia Opioids Market
5.4.3.4.1 Saudi Arabia Opioids Market by Application
5.4.3.4.2 Saudi Arabia Opioids Market by Product Type
5.4.3.5 South Africa Opioids Market
5.4.3.5.1 South Africa Opioids Market by Application
5.4.3.5.2 South Africa Opioids Market by Product Type
5.4.3.6 Nigeria Opioids Market
5.4.3.6.1 Nigeria Opioids Market by Application
5.4.3.6.2 Nigeria Opioids Market by Product Type
5.4.3.7 Rest of LAMEA Opioids Market
5.4.3.7.1 Rest of LAMEA Opioids Market by Application
5.4.3.7.2 Rest of LAMEA Opioids Market by Product Type

Chapter 6. Company Profiles
6.1 Johnson and Johnson
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental &Regional Analysis
6.1.4 Research & Development Expenses
6.2 AstraZeneca PLC
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.3 Boehringer Ingelheim International Gmbh
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Regional & Segmental Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Approvals and Trials:
6.4 Endo International PLC
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental Analysis
6.4.4 Research & Development Expenses
6.5 Mallinckrodt PLC
6.5.1 Company Overview
6.5.1 Financial Analysis
6.5.2 Segmental and Regional Analysis
6.5.3 Research & Development Expense
6.6 Sanofi S.A.
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Acquisition and Mergers:
6.7 Pfizer, Inc.
6.7.1 Company Overview
6.7.1 Financial Analysis
6.7.2 Regional Analysis
6.7.3 Research & Development Expense
6.7.4 Recent strategies and developments:
6.7.4.1 Approvals and Trials:
6.8 Teva Pharmaceutical Industries Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Regional Analysis
6.8.4 Research & Development Expenses
6.8.5 Recent strategies and developments:
6.8.5.1 Product Launches and Product Expansions:
6.8.5.2 Approvals and Trials:
6.9 Sun Pharmaceutical Industries Ltd.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Purdue Pharma L.P.
6.10.1 Company Overview
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo